The Safety and Immunogenicity of an Interleukin-12–Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 InfectionJeffrey M. Jacobson, Nicole Frahm, Pablo Tebas et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2015Cited by 38
Novel Dosing Strategies Increase Exposures of the Potent Antituberculosis Drug Rifapentine but Are Poorly Tolerated in Healthy VolunteersKelly E. Dooley, Radojka M. Savić, Jeong‐Gun Park et al.|Antimicrobial Agents and Chemotherapy|2015Cited by 21